Human medicines European public assessment report (EPAR): Zynlonta, loncastuximab tesirine, Date of authorisation: 20/12/2022, Revision: 6, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 25 November 2025 - 10:20

Human medicines European public assessment report (EPAR): Zynlonta, loncastuximab tesirine, Date of authorisation: 20/12/2022, Revision: 6, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/zynlonta

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters